CH621111A5 - - Google Patents

Download PDF

Info

Publication number
CH621111A5
CH621111A5 CH940676A CH940676A CH621111A5 CH 621111 A5 CH621111 A5 CH 621111A5 CH 940676 A CH940676 A CH 940676A CH 940676 A CH940676 A CH 940676A CH 621111 A5 CH621111 A5 CH 621111A5
Authority
CH
Switzerland
Prior art keywords
amino
formula
pro
gly
acid
Prior art date
Application number
CH940676A
Other languages
English (en)
French (fr)
Inventor
Amedeo Arturo Failli
Hans Ueli Immer
Manfred Karl Goetz
Original Assignee
Ayerst Mckenna & Harrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna & Harrison filed Critical Ayerst Mckenna & Harrison
Publication of CH621111A5 publication Critical patent/CH621111A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH940676A 1975-07-28 1976-07-22 CH621111A5 (US07935154-20110503-C00006.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/599,450 US4018912A (en) 1975-07-28 1975-07-28 Tripeptide derivatives with central nervous system activity and preparation thereof

Publications (1)

Publication Number Publication Date
CH621111A5 true CH621111A5 (US07935154-20110503-C00006.png) 1981-01-15

Family

ID=24399667

Family Applications (1)

Application Number Title Priority Date Filing Date
CH940676A CH621111A5 (US07935154-20110503-C00006.png) 1975-07-28 1976-07-22

Country Status (10)

Country Link
US (1) US4018912A (US07935154-20110503-C00006.png)
JP (1) JPS6033854B2 (US07935154-20110503-C00006.png)
BE (1) BE844603A (US07935154-20110503-C00006.png)
CA (1) CA1062250A (US07935154-20110503-C00006.png)
CH (1) CH621111A5 (US07935154-20110503-C00006.png)
DE (1) DE2633976A1 (US07935154-20110503-C00006.png)
FR (1) FR2319378A1 (US07935154-20110503-C00006.png)
GB (1) GB1523685A (US07935154-20110503-C00006.png)
SE (2) SE431330B (US07935154-20110503-C00006.png)
SU (1) SU632299A3 (US07935154-20110503-C00006.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093713A (en) * 1977-02-28 1978-06-06 Ayerst Mckenna & Harrison Ltd. Dipeptide derivatives with central nervous system activity and preparation thereof
DE3226241A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
DE3226242A1 (de) * 1982-07-14 1984-01-26 Basf Ag, 6700 Ludwigshafen N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer
US5190924A (en) * 1991-02-13 1993-03-02 Boc Health Care, Inc. Peptide amides and amide dimers useful as muscle relaxants
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US6489300B1 (en) * 1997-07-31 2002-12-03 Eugene D. Thorsett Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
DE19813849A1 (de) * 1998-03-27 1999-09-30 Degussa Verfahren zur einstufigen Umsalzung und Aufreinigung von Oligopeptiden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1033905A (en) * 1962-03-30 1966-06-22 Geigy Ag J R Process for the production of a new pentapeptide
NL6707845A (US07935154-20110503-C00006.png) * 1966-06-11 1967-12-12
BE787908A (fr) * 1971-08-24 1973-02-23 Abbott Lab Medicament antidepressif et antiparkinsonien
US3888840A (en) * 1973-02-07 1975-06-10 American Home Prod Novel hydrazinocarboxamide derivatives and preparation thereof

Also Published As

Publication number Publication date
BE844603A (fr) 1977-01-28
FR2319378B1 (US07935154-20110503-C00006.png) 1979-05-04
SU632299A3 (ru) 1978-11-05
DE2633976A1 (de) 1977-02-10
US4018912A (en) 1977-04-19
GB1523685A (en) 1978-09-06
FR2319378A1 (fr) 1977-02-25
JPS5223070A (en) 1977-02-21
JPS6033854B2 (ja) 1985-08-05
SE8006119L (sv) 1980-09-02
CA1062250A (en) 1979-09-11
SE431330B (sv) 1984-01-30

Similar Documents

Publication Publication Date Title
EP0462884B1 (fr) Dérivés de TRH, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CH628324A5 (fr) Procede de preparation de pseudopeptides utiles comme medicaments.
EP0316218B1 (fr) Nouveaux dérivés de l-proline, leur préparation et leurs applications biologiques
FR2460291A1 (fr) Nouveaux tripeptides agissant sur le systeme nerveux central et leur procede de preparation
FR2577557A1 (fr) Peptides et derives peptidiques, leur preparation, leur utilisation en therapeutique et compositions pharmaceutiques les contenant
EP0406119A1 (fr) Nouveaux dérivés peptidiques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CH621111A5 (US07935154-20110503-C00006.png)
EP0046113B1 (fr) Nouveaux peptides et leur application en thérapeutique
CH634041A5 (fr) Derives de la pepstatine, leur preparation et composition les contenant.
EP0261017B1 (fr) Esters d'aminoacides d'alcools cycloaliphatiques, procédé de préparation et utilisation comme médicaments
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
EP0639586B1 (fr) Dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
FR2490491A1 (fr) Composition pharmaceutique analgesique contenant comme ingredient actif l'acide 3-amino-2-hydroxy-4 phenylbutanoique et ses derives et application
FR2460292A1 (fr) Nouveaux tripeptidamides actifs sur le systeme nerveux central et procede de preparation de ceux-ci
EP0052028B1 (fr) Nouveaux hexapeptides, leur préparation, leur application comme médicaments et les compositions les renfermant
BE897546A (fr) Nouveaux polypeptides leur preparation et leur application comme medicaments
EP0188947B1 (fr) Peptides réduits, inhibiteurs de la sécrétion gastrique, procédé d'obtention et compositions pharmaceutiques les contenant
EP0305297B1 (fr) Nouveaux dérivés de l'acide aza - 2 bicyclooctane carboxylique - 3, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CH616652A5 (US07935154-20110503-C00006.png)
EP0129461B1 (fr) Dérivés d'acides isoindoledicarboxyliques, leur préparation et compositions pharmaceutiques les contenant
EP0003456B1 (fr) Dérivés d'amino-3-cardénolides, procédé pour leur préparation, et médicaments les contenant
EP0165151A1 (fr) Dérivés peptidiques inhibiteurs de la rénine, leur procédé de préparation et leur application en thérapeutique
USRE30496E (en) Tripeptide derivatives with central nervous system activity and preparation thereof
FR2479818A1 (en) 2-Substd. phenyl 7-nitro 3H 1,4-benzodiazepinyl aminoacid derivs. - are anxiolytics, tranquillisers, sedatives and anticonvulsants, prepd. by reacting aminoacid or peptide with benzodiazepin-2-thione

Legal Events

Date Code Title Description
PL Patent ceased